A small clinical trial conducted by a research team from the University of Murcia in Spain suggests that specially treated autologous bone marrow cells can integrate into bone tissue, potentially helping patients with severe osteoporosis reduce fractures. This study not only provides a new therapeutic approach for such patients but also explores a pathway in regenerative medicine to utilize therapeutic cells for repairing and rebuilding damaged bone tissue.
